Drug and Alcohol Dependence
Volume 111, Issue 1 , Pages 4-12 , 1 September 2010

Measuring addiction propensity and severity: The need for a new instrument

  • Kevin P. Conway

      Affiliations

    • Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 6001 Executive Blvd., Room 5153, MSC 9589, Bethesda, MD 20892-9589, USA
    • Corresponding Author InformationCorresponding author at: Division of Epidemiology, Services, and Prevention Research (DESPR), National Institute on Drug Abuse, 6001 Executive Blvd., Suite 5185, Bethesda, MD 20892-9589, USA. Tel.: +1 301 443 6504; fax: +1 301 443 2636.
    • ,
  • Janet Levy

      Affiliations

    • Duke University School of Nursing, SON New Building, Room 1019, 307 Trent Drive, Durham, NC 27710, USA
    • ,
  • Michael Vanyukov

      Affiliations

    • Departments of Pharmaceutical Sciences, Psychiatry and Human Genetics, University of Pittsburgh, SALK 528, Pittsburgh, PA 15260, USA
    • ,
  • Redonna Chandler

      Affiliations

    • Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 6001 Executive Blvd., Room 5153, MSC 9589, Bethesda, MD 20892-9589, USA
    • ,
  • Joni Rutter

      Affiliations

    • Division of Basic Neuroscience and Behavioral Research, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 6001 Executive Blvd., Room 4282, MSC 9589, Rockville, MD 20852, USA
    • ,
  • Gary E. Swan

      Affiliations

    • Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA
    • ,
  • Michael Neale

      Affiliations

    • Department of Psychiatry, Virginia Commonwealth University, 1200 East Broad Street, PO Box 980710, Richmond, VA 23298-0710, USA

Received 30 June 2009 ,Revised 1 March 2010 ,Accepted 2 March 2010.

References 

  1. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv. Rev. Psychiatry. 2004;12:305–320
  2. Baillie AJ, Mattick RP. The benzodiazepine dependence questionnaire: development, reliability and validity. Br. J. Psychiatry. 1996;169:276–281
  3. Bierut LJ, Dinwiddie SH, Begleiter H, Crowe RR, Hesselbrock V, Nurnberger JI, et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch. Gen. Psychiatry. 1998;55:982–988
  4. Brody GH, Beach SR, Philibert RA, Chen YF, Lei MK, Murry VM, et al. Parenting moderates a genetic vulnerability factor in longitudinal increases in youths’ substance use. J. Consult. Clin. Psychol. 2009;77:1–11
  5. Button TM, Hewitt JK, Rhee SH, Young SE, Corley RP, Stallings MC. Examination of the causes of covariation between conduct disorder symptoms and vulnerability to drug dependence. Twin Res. Hum. Genet. 2006;9:38–45
  6. Cadoret RJ, Yates WR, Troughton E, Woodworth G, Stewart MA. Adoption study demonstrating two genetic pathways to drug abuse. Arch. Gen. Psychiatry. 1995;52:42–52
  7. Chan YF, Dennis ML, Funk RR. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J. Subst. Abuse Treat. 2008;34:14–24
  8. Chassin L, Rogosch F, Barrera M. Substance use and symptomatology among adolescent children of alcoholics. J. Abnorm. Psychol. 1991;100:449–463
  9. Churchill AC, Burgess PM, Pead J, Gill T. Measurement of the severity of amphetamine dependence. Addiction. 1993;88:1335–1340
  10. Compton WM, Saha TD, Conway KP, Grant BF. The role of cannabis use within a dimensional approach to cannabis use disorders. Drug Alcohol Depend. 2009;100:221–227
  11. Conway KP, Kane RJ, Ball SA, Poling JC, Rounsaville BJ. Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend. 2003;71:65–75
  12. Conway KP, Swendsen JD, Rounsaville BJ, Merikangas KR. Personality, drug of choice, and comorbid psychopathology among substance abusers. Drug Alcohol Depend. 2002;65:225–234
  13. Conway KP, Compton WM, Miller PM. Editorial: Novel approaches to phenotyping drug abuse. Addict. Behav. 2006;31:923–928
  14. Craddock N, O’Donovan MC, Owen MJ. Genome-wide association studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric phenotypes. Mol. Psychiatry. 2008;13:649–653
  15. Dawson DA, Grant BF, Stinson FS, Chou PS. Maturing out of alcohol dependence: the impact of transitional life events. J. Stud. Alcohol. 2006;67:195–203
  16. Dennis M, Scott CK. Managing addiction as a chronic condition. Addict. Sci. Clin. Pract. 2007;4:45–55
  17. Dennis M, Titus J, Unsicker J, Hodkgins D. Global Appraisal of Individual Needs: Administration Guide for the GAIN and Related Measures. Bloomington, IL: Chestnut Health Systems; 2003;
  18. Dennis ML, Chan YF, Funk RR. Development and validation of the GAIN short screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. Am. J. Addict. 2006;15:80–91
  19. Dennis ML, Scott CK, Funk R, Foss MA. The duration and correlates of addiction and treatment careers. J. Subst. Abuse Treat. 2005;28(Suppl. 1):S51–S62
  20. Dick DM, Aliev F, Wang JC, Grucza RA, Schuckit M, Kuperman S, et al. Using dimensional models of externalizing psychopathology to aid in gene identification. Arch. Gen. Psychiatry. 2008;65:310–318
  21. Drasgow F, Olson-Buchanan JB. Innovations in Computerized Assessment. Mahwah: Lawrence Erlbaum Associates; 1999;
  22. Edwards G, Gross MM. Alcohol dependence—provisional description of a clinical syndrome. Br. Med. J. 1976;1:1058–1061
  23. Elkins IJ, McGue M, Malone S, Iacono WG. The effect of parental alcohol and drug disorders on adolescent personality. Am. J. Psychiatry. 2004;161:670–676
  24. Embretson SE, Reise WSP. Item Response Theory for Psychologists. Mahwah, NJ: Lawrence Erlbaum Associates; 2000;
  25. Falconer DS. The inheritance of liability to certain diseases, estimate from the incidence among relatives. Ann. Hum. Genet. 1965;29:51–71
  26. Foll BL, Gallo A, Le SY, Lu L, Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav. Pharmacol. 2009;20:1–17
  27. Gillespie NA, Neale MC, Prescott CA, Aggen SH, Kendler KS. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction. 2007;102:920–930
  28. Gilmore CS, Malone SM, Bernat EM, Iacono WG. Relationship between the P3 event-related potential, its associated time–frequency components, and externalizing psychopathology. Psychophysiology. 2009;
  29. Glantz MD, Conway KP, Colliver JD. Drug abuse heterogeneity and the search for subtypes. In:  Sloboda Z editors. Epidemiology of Drug Abuse. New York: Kluwer Academic/Plenum Publishers; 2005;p. 15–28
  30. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry. 2002;159:1642–1652
  31. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The Severity of Dependence Scale (Sds)—psychometric properties of the Sds in English and Austrian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607–614
  32. Hambleton RK, Swaminathan HS. Item Response Theory Principles and Applications. Boston: Kluwer Nijhoff Publishing; 1985;
  33. Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of item response theory. Newbury Park, CA: Sage; 1991;
  34. Hariri AR. The neurobiology of individual differences in complex behavioral traits. Annu. Rev. Neurosci. 2009;32:225–247
  35. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F, et al. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol. Psychiatry. 2008;
  36. Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood—implications for substance-abuse prevention. Psychol. Bull. 1992;112:64–105
  37. Hawkins JD, Kosterman R, Catalano RF, Hill KG, Abbott RD. Effects of social development intervention in childhood 15 years later. Arch. Pediatr. Adolesc. Med. 2008;162:1133–1141
  38. Hicks BM, Bernat E, Malone SM, Iacono WG, Patrick CJ, Krueger RF, et al. Genes mediate the association between P3 amplitude and externalizing disorders. Psychophysiology. 2007;44:98–105
  39. Hicks, B.M., Iacono, W.G., McGue, M., in press. Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomes. Addiction.
  40. Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ. Family transmission and heritability of externalizing disorders: a twin-family study. Arch. Gen. Psychiatry. 2004;61:922–928
  41. Hodgins DC, Elguebaly N. More data on the addiction severity index—reliability and validity with the mentally-Ill substance-abuser. J. Nerv. Ment. Dis. 1992;180:197–201
  42. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 2006;29:565–598
  43. Iacono WG, Carlson SR, Malone SM, McGue M. P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys. Arch. Gen. Psychiatry. 2002;59:750–757
  44. Iacono WG, Carlson SR, Taylor J, Elkins IJ, McGue M. Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev. Psychopathol. 1999;11:869–900
  45. Iacono WG, Malone SM, McGue M. Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annu. Rev. Clin. Psychol. 2008;4:325–348
  46. Justus AN, Finn PR, Steinmetz JE. P300, disinhibited personality, and early-onset alcohol problems. Alcohol. Clin. Exp. Res. 2001;25:1457–1466
  47. Kahler CW, Strong DR, Hayaki J, Ramsey SE, Brown RA. An item response analysis of the alcohol dependence scale in treatment-seeking alcoholics. J. Stud. Alcohol. 2003;64:127–136
  48. Kahler CW, Strong DR, Stuart GL, Moore TM, Ramsey SE. Item functioning of the alcohol dependence scale in a high-risk sample. Drug Alcohol Depend. 2003;72:183–192
  49. Kalivas PW, O’Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology. 2007;33:166–180
  50. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry. 2005;162:1403–1413
  51. Kellam SG, Brown CH, Poduska JM, Ialongo NS, Wang W, Toyinbo P, et al. Effects of a universal classroom behavior management program in first and second grades on young adult behavioral, psychiatric, and social outcomes. Drug Alcohol Depend. 2008;95(Suppl. 1):S5–S28
  52. Kendler KS, Karkowski LM, Neale MC, Prescott CA. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch. Gen. Psychiatry. 2000;57:261–269
  53. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am. J. Psychiatry. 2003;160:687–695
  54. Kendler KS, Myers J, Prescott CA. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch. Gen. Psychiatry. 2007;64:1313–1320
  55. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry. 2003;60:929–937
  56. Kirillova GP, Vanyukov MM, Kirisci L, Reynolds M. Physical maturation, peer environment, and the ontogenesis of substance use disorders. Psychiatry Res. 2008;158:43–53
  57. Kirisci, L., Hsu, T., 1992. Ability Estimation Using Only Observable Quantities in Adaptive Testing. ERIC Document Reproduction Service No. TM 018393.
  58. Kirisci L, Mezzich A, Tarter R. Norms and sensitivity of the adolescent version of the drug-use screening inventory. Addict. Behav. 1995;20:149–157
  59. Kirisci L, Tarter R, Mezzich A, Ridenour T, Reynolds M, Vanyukov M. Prediction of cannabis use disorder between boyhood and young adulthood clarifying the phenotype and environtype. Am. J. Addict. 2009;18:36–47
  60. Kirisci L, Tarter RE, Vanyukov M, Martin C, Mezzich A, Brown S. Application of item response theory to quantify substance use disorder severity. Addict. Behav. 2006;31:1035–1049
  61. Kirisci L, Vanyukov M, Dunn M, Tarter R. Item response theory modeling of substance use: an index based on 10 drug categories. Psychol. Addict. Behav. 2002;16:290–298
  62. Koob GF, Le MM. Drug abuse: hedonic homeostatic dysregulation. Science. 1997;278:52–58
  63. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2009;
  64. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 2005;8:1450–1457
  65. Krueger RF, Hicks BM, Patrick CJ, Carlson SR, Iacono WG, McGue M. Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J. Abnorm. Psychol. 2002;111:411–424
  66. Krueger RF, Markon KE, Patrick CJ, Benning SD, Kramer MD. Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum. J. Abnorm. Psychol. 2007;116:645–666
  67. Langbehn DR, Cadoret RJ, Caspers K, Troughton EP, Yucuis R. Genetic and environmental risk factors for the onset of drug use and problems in adoptees. Drug Alcohol Depend. 2003;69:151–167
  68. Langenbucher JW, Morgenstern J, Miller KJ. Dsm-Iii, Dsm-Iv and Icd-10 as severity scales for drug-dependence. Drug Alcohol Depend. 1995;39:139–150
  69. Li MD, Burmeister M. New insights into the genetics of addiction. Nat. Rev. Genet. 2009;10:225–231
  70. Lord FM, Novick MR. Statistical Theories of Mental Test Scores. Reading, MA: Addison-Wesley Publishing Company; 1968;
  71. McDermott PA, Alterman AI, Brown L, Zaballero A, Snider EC, Mckay JR. Construct refinement and confirmation for the addiction severity index. Psychol. Assess. 1996;8:182–189
  72. Mcgovern MP, Morrison DH. The Chemical Use, Abuse, and Dependence Scale (Cuad)—rationale, reliability, and validity. J. Subst. Abuse Treat. 1992;9:27–38
  73. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the addiction severity index—reliability and validity in 3 centers. J. Nerv. Ment. Dis. 1985;173:412–423
  74. McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J. Nerv. Ment. Dis. 1980;168:26–33
  75. Merikangas KR, Conway KP. Genetic epidemiology of substance use disorders. In:  Charney DS,  Nester EJ editor. Neurobiology of Mental Illness. New York: Oxford University Press; 2009;p. 786–800
  76. Merikangas KR, Conway KP. Genetic epidemiology of substance use disorders. In:  Charney DS,  Nester EJ editor. Neurobiology of Mental Illness. third. 2008;
  77. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, et al. Familial transmission of substance use disorders. Arch. Gen. Psychiatry. 1998;55:973–979
  78. Merikangas KR, Avenevoli S. Implications of genetic epidemiology for the prevention of substance use disorders. Addict. Behav. 2000;25:807–820
  79. Miele GM, Carpenter KM, Cockerham MS, Trautman KD, Blaine J, Hasin DS. Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug Alcohol Depend. 2000;59:63–75
  80. Moffitt TE. Genetic and environmental influences on antisocial behaviors: evidence from behavioral-genetic research. Adv. Genet. 2005;55:41–104
  81. Mustanski BS, Viken RJ, Kaprio J, Rose RJ. Genetic influences on the association between personality risk factors and alcohol use and abuse. J. Abnorm. Psychol. 2003;112:282–289
  82. Neale MC, Aggen SH, Maes HH, Kubarych TS, Schmitt JE. Methodological issues in the assessment of substance use phenotypes. Addict. Behav. 2006;31:1010–1034
  83. Newcomb MD, Galaif ER, Locke TF. Substance use diagnoses within a community sample of adults: distinction, comorbidity, and progression over time. Prof. Psychol.: Res. Pract. 2001;32:239–247
  84. O’Brien CP. Research advances in the understanding and treatment of addiction. Am. J. Addict. 2003;12:S36–S47
  85. Patkar AA, Mannelli P, Peindl K, Hill KP, Wu LT, Lee T, et al. Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence. J. Psychiatr. Res. 2008;42:1213–1219
  86. Poduska JM, Kellam SG, Wang W, Brown CH, Ialongo NS, Toyinbo P. Impact of the Good Behavior Game, a universal classroom-based behavior intervention, on young adult service use for problems with emotions, behavior, or drugs or alcohol. Drug Alcohol Depend. 2008;95(Suppl. 1):S29–S44
  87. Reich T, Cloninger CR, Van EP, Rice JP, Mullaney J. Secular trends in the familial transmission of alcoholism. Alcohol. Clin. Exp. Res. 1988;12:458–464
  88. Riley BB, Conrad KJ, Bezruczko N, Dennis ML. Relative precision, efficiency and construct validity of different starting and stopping rules for a computerized adaptive test: the GAIN substance problem scale. J. Appl. Meas. 2007;8
  89. Romer D, Walker EF. Adolescent Psychopathology and the Developing Brain: Integrating Brain and Prevention Science. New York: Oxford University Press; 2007;
  90. Saha TD, Stinson FS, Grant BF. The role of alcohol consumption in future classifications of alcohol use disorders. Drug Alcohol Depend. 2007;89:82–92
  91. Saxon AJ, Oreskovich MR, Brkanac Z. Genetic determinants of addiction to opioids and cocaine. Harv. Rev. Psychiatry. 2005;13:218–232
  92. Schuckit MA. An overview of genetic influences in alcoholism. J. Subst. Abuse Treat. 2009;36:S5–S14
  93. Schuckit MA, Goodwin DA, Winokur G. A study of alcoholism in half siblings. Am. J. Psychiatry. 1972;128:1132–1136
  94. Sher KJ, Bartholow BD, Wood MD. Personality and substance use disorders: a prospective study. J. Consult. Clin. Psychol. 2000;68:818–829
  95. Skinner HA, Allen BA. Alcohol dependence syndrome—measurement and validation. J. Abnorm. Psychol. 1982;91:199–209
  96. Slutske WS, Heath AC, Madden PA, Bucholz KK, Statham DJ, Martin NG. Personality and the genetic risk for alcohol dependence. J. Abnorm. Psychol. 2002;111:124–133
  97. Stockwell T, Hodgson R, Edwards G, Taylor C, Rankin H. Development of a questionnaire to measure severity of alcohol dependence. Br. J. Addict. 1979;74:79–87
  98. Strong DR, Brown RA, Ramsey SE, Myers MG. Nicotine dependence measures among adolescents with psychiatric disorders: evaluating symptom expression as a function of dependence severity. Nicotine Tob. Res. 2003;5:735–746
  99. Strong DR, Kahler CW, Abrantes AM, MacPherson L, Myers MG, Ramsey SE, et al. Nicotine dependence symptoms among adolescents with psychiatric disorders: using a Rasch model to evaluate symptom expression across time. Nicotine Tob. Res. 2007;9:557–569
  100. Strong DR, Kahler CW, Colby SM, Griesler PC, Kandel D. Linking measures of adolescent nicotine dependence to a common latent continuum. Drug Alcohol Depend. 2009;99:296–308
  101. Strong DR, Kahler CW, Ramsey SE, Brown RA. Finding order in the DSM-IV nicotine dependence syndrome: a Rasch analysis. Drug Alcohol Depend. 2003;72:151–162
  102. Sutherland G, Edwards G, Taylor C, Phillips G, Gossop M, Brady R. The measurement of opiate dependence. Br. J. Addict. 1986;81:485–494
  103. Swendsen JD, Conway KP, Rounsaville BJ, Merikangas KR. Are personality traits familial risk factors for substance use disorders? Results of a controlled family study. Am. J. Psychiatry. 2002;159:1760–1766
  104. Tarter RE, Kirisci L, Habeych M, Reynolds M, Vanyukov M. Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood: direct and mediated etiologic pathways. Drug Alcohol Depend. 2004;73:121–132
  105. Tarter RE, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M, et al. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am. J. Psychiatry. 2003;160:1078–1085
  106. Tarter RE, Laird SB, Kabene M, Bukstein O, Kaminer Y. Drug-abuse severity in adolescents is associated with magnitude of deviation in temperament traits. Br. J. Addict. 1990;85:1501–1504
  107. Tarter RE, Vanyukov M. Theoretical and operational framework for research into the etiology of substance use disorders. J. Child Adoles. Subst. Abuse. 1991;10:1–12
  108. Tarter RE, Vanyukov M. Alcoholism: a developmental disorder. J. Consult. Clin. Psychol. 1994;62:1096–1107
  109. Tarter RE, Vanyukov M, Kirisci L, Reynolds M, Clark DB. Predictors of marijuana use in adolescents before and after licit drug use: examination of the gateway hypothesis. Am. J. Psychiatry. 2006;163:2134–2140
  110. Topp L, Mattick RP. Validation of the amphetamine dependence syndrome and the SamDQ. Addiction. 1997;92:151–162
  111. Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am. J. Med. Genet. 1996;67:473–477
  112. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch. Gen. Psychiatry. 1998;55:967–972
  113. Uhl GR. Molecular Genetics of Substance Abuse Vulnerability: Remarkable Recent Convergence of Genome Scan Results. New York: New York Acad Sciences; 2004;
  114. Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Komiyama T, et al. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry. 2008;65:345–355
  115. Vanyukov M, Kirisci L, Moss L, Tarter RE, Reynolds M, Maher BS, et al. Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability. Behav. Genet. 2009;39:233–244
  116. Vanyukov MM, Kirisci L, Tarter RE, Simkevitz HF, Kirillova GP, Maher BS, et al. Liability to substance use disorders: 2. A measurement approach. Neurosci. Biobehav. Rev. 2003;27:517–526
  117. Vanyukov MM, Maher BS, Devlin B, Kirillova GP, Kirisci L, Yu LM, et al. The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene–environment interaction. Psychiatr. Genet. 2007;17:323–332
  118. Vanyukov MM, Tarter RE. Genetic studies of substance abuse. Drug Alcohol Depend. 2000;59:101–123
  119. Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB. Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci. Biobehav. Rev. 2003;27:507–515
  120. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J. Clin. Invest. 2003;111:1444–1451
  121. Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry. 2004;9:557–569
  122. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 2006;26:6583–6588
  123. Winokur G, Reich T, Rimmer J, Pitts FN. Alcoholism. 3. Diagnosis and familial psychiatric illness in 259 alcoholic probands. Arch. Gen. Psychiatry. 1970;23:104–111
  124. Wu LT, Pan JJ, Blazer DG, Tai B, Stitzer ML, Brooner RK, et al. An item response theory modeling of alcohol and marijuana dependences: A National Drug Abuse Treatment Clinical Trials Network study. J. Stud. Alcohol Drugs. 2009;70:414–425
  125. Young SE, Friedman NP, Miyake A, Willcutt EG, Corley RP, Haberstick BC, et al. Behavioral disinhibition: liability for externalizing spectrum disorders and its genetic and environmental relation to response inhibition across adolescence. J. Abnorm. Psychol. 2009;118:117–130
  126. Young SE, Stallings MC, Corley RP, Krauter KS, Hewitt JK. Genetic and environmental influences on behavioral disinhibition. Am. J. Med. Genet. 2000;96:684–695

☆ Disclaimer: The views and opinions expressed in this paper are those of the authors and do not necessarily represent the views of the National Institute on Drug Abuse, National Institutes of Health, or any other governmental agency.

PII: S0376-8716(10)00112-2

doi: 10.1016/j.drugalcdep.2010.03.011

Drug and Alcohol Dependence
Volume 111, Issue 1 , Pages 4-12 , 1 September 2010

Article Tools

* Image Usage & Resolution